Arena Up Tue. In Pharma Rally Before Diet Pill Review
Shares of biopharma stocks jumped Monday as regulatory decisions on a pair of new diet pills grow near. Arena Pharmaceuticals (ARNA) rallied 12% early. The company expects a decision from the Food and Drug Administration on lorcaserin, its experimental diet drug, on June 27. On May 10, a panel of outside experts voted 18 to 4 to recommend approval. If it wins full FDA approval, lorcaserin would be one of the first new diet drugs in more than a
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here